Targeting PARP1 in XRCC1 Deficient Sporadic Invasive Breast Cancer or Pre-Invasive Ductal Carcinoma in Situ Induces Synthetic Lethality and Chemoprevention

Cancer Research - United States
doi 10.1158/0008-5472.can-18-0633

Related search